Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcomes of Breast Cancer Patients Receiving Levobupivacaine Wound Infiltration or Diclofenac for Postoperative Pain Relief

NCT05829707 is registered in ClinicalTrials.gov with Osijek University Hospital as lead sponsor.

NCT NCT05829707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05829707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcomes of Breast Cancer Patients Receiving Levobupivacaine Wound Infiltration or Diclofenac for Postoperative Pain Relief
Lead sponsor
Osijek University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 5, 2009
Completion date
April 5, 2023
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, chronic shoulder pain, hand strength, health related quality of life, lymph node dissection, postoperative analgesia, surgical wound infiltration